Addiction Treatment
Does Medication-Assisted Treatment Work?
Medication-assisted treatment, or MAT, pairs an FDA-approved medication with counseling to treat opioid or alcohol use disorder. The question in the title has a short answer. Yes. For the conditions it is designed for, it works better than counseling alone, and the evidence behind that is about as strong as anything in addiction medicine.
The longer answer covers what “works” means, which medications do what, who MAT suits, and where the limits are.
What MAT actually is
MAT is not one drug. It is a category, and the medications inside it do different jobs.
For opioid use disorder there are three:
- Buprenorphine (Suboxone, Sublocade, and others). A partial opioid agonist. It occupies the same receptors as heroin or fentanyl, enough to stop withdrawal and cravings, but with a ceiling that makes overdose far less likely. It can be prescribed in an office setting, including outpatient programs like ours.
- Methadone. A full agonist, dispensed daily through licensed opioid treatment programs. Decades of evidence. Not something we dispense, but something we can help you access.
- Naltrexone (Vivitrol as a monthly injection). Blocks opioid receptors entirely. Nothing to misuse, but you have to be fully withdrawn before starting.
For alcohol use disorder there are also three. Naltrexone dulls the reward from drinking. Acamprosate eases the long tail of post-acute withdrawal. Disulfiram makes you sick if you drink.
Notice what is not on the list. There is no FDA-approved medication for cocaine, methamphetamine, or cannabis use disorder. MAT is a treatment for opioids and alcohol. For everything else, the work is therapeutic.
What the evidence says
The strongest data is for opioids. People with opioid use disorder who are treated with methadone or buprenorphine die at roughly half the rate of those who are not. That is the finding of a 2017 meta-analysis in the BMJ that pooled cohort studies covering more than 100,000 people, and it has held up since. Treatment with these medications also reduces illicit opioid use, overdose, infectious disease transmission, and arrests, and it keeps people in treatment longer, which is where the other gains come from.
For alcohol, the effect is real but more modest. Naltrexone and acamprosate each reduce the chance of returning to heavy drinking for a meaningful share of the people who take them. They are badly underused. The National Institute on Alcohol Abuse and Alcoholism has said for years that most people with alcohol use disorder are never offered one.
Why it works
Addiction changes the brain’s reward and stress systems. Opioids in particular leave a person who has stopped using in a state of persistent withdrawal, anxiety, and craving that can last months. Willpower is a poor match for a nervous system that is screaming.
Medication quiets that signal. With cravings and withdrawal managed, the person can actually attend therapy, hold a job, sleep, and think.
That is the whole mechanism. MAT does not do the recovery. It makes the recovery possible to do.
The myth that will not die
“MAT just replaces one addiction with another.” We hear it from families, and sometimes from people in recovery communities.
It confuses dependence with addiction. Someone on a stable dose of buprenorphine is physically dependent on it, the way someone with diabetes depends on insulin. What they do not have is the compulsive, escalating, life-wrecking use that defines addiction. They are not chasing a high. They are not overdosing. They are not buying fentanyl in a parking lot.
A person on MAT holding down a job and showing up for their kids is in recovery. That is not a technicality. It is the point.
Who MAT is for
MAT is appropriate for:
- Moderate to severe opioid use disorder. For most people in this group it should be the default, not a fallback after counseling fails
- Alcohol use disorder where cravings or repeated relapse are part of the pattern
- Anyone leaving detox, jail, or a residential program, when tolerance has dropped and overdose risk is at its highest
It is less clear-cut for mild disorders, and it does not apply to stimulant or cannabis addiction. The decision belongs in an assessment, with a prescriber who knows your history.
How long? As long as it is helping. Some people use buprenorphine for a year, some for many years. Tapering off too early is one of the most common ways people relapse, and there is no prize for coming off medication on a schedule someone else picked.
MAT at South Jersey Recovery Program
We offer medication-assisted treatment in Berlin, NJ as part of outpatient care, not as a standalone prescription. The medication is paired with individual therapy, group therapy, and, where it applies, dual diagnosis treatment for the depression or anxiety that so often sits underneath.
You can receive MAT at any of our three levels of care: partial care, intensive outpatient, or outpatient. We do not provide medically supervised detox. If you need one first, we will help you get there and start with you when it is done.
The bottom line
Does MAT work? For opioid and alcohol use disorder, medication combined with counseling produces better outcomes than counseling alone, and for opioids the difference is measured in lives.
If you have been told MAT is a crutch, get a second opinion from someone who reads the research. Call (856) 788-6914 or contact us online to ask whether MAT fits your situation. The assessment is free.
Medication is not the easy way out. It is the way that keeps more people alive long enough to do the hard part.